News Headlines Article

Cancer specialists urge letting Medicare negotiate drug prices
Modern Healthcare

Cancer patients who receive life-prolonging drugs often face bills for those therapies that are several times greater than their annual family income. That was one of a number of concerns expressed in commentary published Thursday by more than 100 cancer specialists from across the country. They urged federal involvement in addressing soaring drug prices, which they say ultimately harms patients.“The good news is that effective new cancer therapies are being developed by pharmaceutical and biotechnology companies,” said the letter posted online in the Mayo Clinic Proceedings.